The Effect of Transvenous Pacemaker and Implantable Cardioverter Defibrillator Lead Placement on Tricuspid Valve Function: An Observational Study
This study assessed the effect of transtricuspid placement of permanent pacemaker (PPM) and implantable cardioverter defibrillator (ICD) leads on tricuspid regurgitation (TR) in 248 patients with echocardiograms before and after placement. Some 21.2% of patients with baseline mild TR or less develop...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Society of Echocardiography 2008-03, Vol.21 (3), p.284-287 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 287 |
|---|---|
| container_issue | 3 |
| container_start_page | 284 |
| container_title | Journal of the American Society of Echocardiography |
| container_volume | 21 |
| creator | Kim, Juyong B., MD, MPH Spevack, Daniel M., MD Tunick, Paul A., MD Bullinga, John R., MD Kronzon, Itzhak, MD Chinitz, Larry A., MD Reynolds, Harmony R., MD |
| description | This study assessed the effect of transtricuspid placement of permanent pacemaker (PPM) and implantable cardioverter defibrillator (ICD) leads on tricuspid regurgitation (TR) in 248 patients with echocardiograms before and after placement. Some 21.2% of patients with baseline mild TR or less developed abnormal TR (3.4% mild-moderate, 12.8% moderate, 1.1% moderate-severe, 3.9% severe) after implant. TR worsened by 1 grade or more after implant in 24.2% (20.7% of PPMs vs. 32.4% of ICDs; P < .05). TR worsening was more common with ICDs than PPMs in patients with baseline mild TR or less. After lead implantation, abnormal TR developed in 21.2% and severe TR developed in 3.9% of patients with initially normal TR. TR worsened by at least 1 grade in 24.2%. Patients with ICDs had a higher rate of TR worsening compared with patients with PPMs (32.4% vs. 20.1%; P < .05). |
| doi_str_mv | 10.1016/j.echo.2007.05.022 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70354631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0894731707003999</els_id><sourcerecordid>70354631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-ec34e1f0bc2f0185c1d7457e398223bec9a62a7d334d3aab9a305c674ddd36753</originalsourceid><addsrcrecordid>eNp9klGL1DAUhYMo7rj6B3yQPPnWetM0TSsiLLO7ujCwCzv6GtLkls1sJx2TtjA_w39sygwIPvgULjnnwLnfJeQ9g5wBqz7tcjRPQ14AyBxEDkXxgqwYNDKrZCNekhXUTZlJzuQFeRPjDgBEDfCaXDBZQdmIekV-b5-Q3nQdmpEOHd0G7eOMfpgifdAG9_oZA9Xe0rv9odd-1G2PdK2DdcOMYUyf19i5Nri-1-MQ6Aa1pQ_9YkWfIn2KdGaKB2fpT93PSG8nb0Y3-M_0ytP7NmKY9TLrnj6Okz2-Ja863Ud8d34vyY_bm-36e7a5_3a3vtpkppRizNDwElkHrSk6YLUwzMpSSORNXRS8RdPoqtDScl5arnXbaA7CVLK01vJKCn5JPp5yD2H4NWEc1d5Fg6mHx1RfSeCirDhLwuIkNGGIMWCnDsHtdTgqBmoBoXZqAaEWEAqESiCS6cM5fWr3aP9azptPgi8nAaaOs8OgonHoDVoXEgxlB_f__K__2E3vvDO6f8Yjxt0whbTRqJiKhQL1uJzCcgkgAXjTNPwPHPuxAQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70354631</pqid></control><display><type>article</type><title>The Effect of Transvenous Pacemaker and Implantable Cardioverter Defibrillator Lead Placement on Tricuspid Valve Function: An Observational Study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kim, Juyong B., MD, MPH ; Spevack, Daniel M., MD ; Tunick, Paul A., MD ; Bullinga, John R., MD ; Kronzon, Itzhak, MD ; Chinitz, Larry A., MD ; Reynolds, Harmony R., MD</creator><creatorcontrib>Kim, Juyong B., MD, MPH ; Spevack, Daniel M., MD ; Tunick, Paul A., MD ; Bullinga, John R., MD ; Kronzon, Itzhak, MD ; Chinitz, Larry A., MD ; Reynolds, Harmony R., MD</creatorcontrib><description>This study assessed the effect of transtricuspid placement of permanent pacemaker (PPM) and implantable cardioverter defibrillator (ICD) leads on tricuspid regurgitation (TR) in 248 patients with echocardiograms before and after placement. Some 21.2% of patients with baseline mild TR or less developed abnormal TR (3.4% mild-moderate, 12.8% moderate, 1.1% moderate-severe, 3.9% severe) after implant. TR worsened by 1 grade or more after implant in 24.2% (20.7% of PPMs vs. 32.4% of ICDs; P < .05). TR worsening was more common with ICDs than PPMs in patients with baseline mild TR or less. After lead implantation, abnormal TR developed in 21.2% and severe TR developed in 3.9% of patients with initially normal TR. TR worsened by at least 1 grade in 24.2%. Patients with ICDs had a higher rate of TR worsening compared with patients with PPMs (32.4% vs. 20.1%; P < .05).</description><identifier>ISSN: 0894-7317</identifier><identifier>EISSN: 1097-6795</identifier><identifier>DOI: 10.1016/j.echo.2007.05.022</identifier><identifier>PMID: 17604958</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Aged ; Cardiovascular ; Defibrillators, Implantable - statistics & numerical data ; Electrodes, Implanted - statistics & numerical data ; Female ; Humans ; Incidence ; Male ; New York - epidemiology ; Pacemaker, Artificial - statistics & numerical data ; Prosthesis Implantation - methods ; Prosthesis Implantation - statistics & numerical data ; Risk Assessment - methods ; Risk Factors ; Treatment Outcome ; Tricuspid Valve Insufficiency - diagnostic imaging ; Tricuspid Valve Insufficiency - epidemiology ; Ultrasonography</subject><ispartof>Journal of the American Society of Echocardiography, 2008-03, Vol.21 (3), p.284-287</ispartof><rights>American Society of Echocardiography</rights><rights>2008 American Society of Echocardiography</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-ec34e1f0bc2f0185c1d7457e398223bec9a62a7d334d3aab9a305c674ddd36753</citedby><cites>FETCH-LOGICAL-c475t-ec34e1f0bc2f0185c1d7457e398223bec9a62a7d334d3aab9a305c674ddd36753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0894731707003999$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17604958$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Juyong B., MD, MPH</creatorcontrib><creatorcontrib>Spevack, Daniel M., MD</creatorcontrib><creatorcontrib>Tunick, Paul A., MD</creatorcontrib><creatorcontrib>Bullinga, John R., MD</creatorcontrib><creatorcontrib>Kronzon, Itzhak, MD</creatorcontrib><creatorcontrib>Chinitz, Larry A., MD</creatorcontrib><creatorcontrib>Reynolds, Harmony R., MD</creatorcontrib><title>The Effect of Transvenous Pacemaker and Implantable Cardioverter Defibrillator Lead Placement on Tricuspid Valve Function: An Observational Study</title><title>Journal of the American Society of Echocardiography</title><addtitle>J Am Soc Echocardiogr</addtitle><description>This study assessed the effect of transtricuspid placement of permanent pacemaker (PPM) and implantable cardioverter defibrillator (ICD) leads on tricuspid regurgitation (TR) in 248 patients with echocardiograms before and after placement. Some 21.2% of patients with baseline mild TR or less developed abnormal TR (3.4% mild-moderate, 12.8% moderate, 1.1% moderate-severe, 3.9% severe) after implant. TR worsened by 1 grade or more after implant in 24.2% (20.7% of PPMs vs. 32.4% of ICDs; P < .05). TR worsening was more common with ICDs than PPMs in patients with baseline mild TR or less. After lead implantation, abnormal TR developed in 21.2% and severe TR developed in 3.9% of patients with initially normal TR. TR worsened by at least 1 grade in 24.2%. Patients with ICDs had a higher rate of TR worsening compared with patients with PPMs (32.4% vs. 20.1%; P < .05).</description><subject>Aged</subject><subject>Cardiovascular</subject><subject>Defibrillators, Implantable - statistics & numerical data</subject><subject>Electrodes, Implanted - statistics & numerical data</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>New York - epidemiology</subject><subject>Pacemaker, Artificial - statistics & numerical data</subject><subject>Prosthesis Implantation - methods</subject><subject>Prosthesis Implantation - statistics & numerical data</subject><subject>Risk Assessment - methods</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><subject>Tricuspid Valve Insufficiency - diagnostic imaging</subject><subject>Tricuspid Valve Insufficiency - epidemiology</subject><subject>Ultrasonography</subject><issn>0894-7317</issn><issn>1097-6795</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9klGL1DAUhYMo7rj6B3yQPPnWetM0TSsiLLO7ujCwCzv6GtLkls1sJx2TtjA_w39sygwIPvgULjnnwLnfJeQ9g5wBqz7tcjRPQ14AyBxEDkXxgqwYNDKrZCNekhXUTZlJzuQFeRPjDgBEDfCaXDBZQdmIekV-b5-Q3nQdmpEOHd0G7eOMfpgifdAG9_oZA9Xe0rv9odd-1G2PdK2DdcOMYUyf19i5Nri-1-MQ6Aa1pQ_9YkWfIn2KdGaKB2fpT93PSG8nb0Y3-M_0ytP7NmKY9TLrnj6Okz2-Ja863Ud8d34vyY_bm-36e7a5_3a3vtpkppRizNDwElkHrSk6YLUwzMpSSORNXRS8RdPoqtDScl5arnXbaA7CVLK01vJKCn5JPp5yD2H4NWEc1d5Fg6mHx1RfSeCirDhLwuIkNGGIMWCnDsHtdTgqBmoBoXZqAaEWEAqESiCS6cM5fWr3aP9azptPgi8nAaaOs8OgonHoDVoXEgxlB_f__K__2E3vvDO6f8Yjxt0whbTRqJiKhQL1uJzCcgkgAXjTNPwPHPuxAQ</recordid><startdate>20080301</startdate><enddate>20080301</enddate><creator>Kim, Juyong B., MD, MPH</creator><creator>Spevack, Daniel M., MD</creator><creator>Tunick, Paul A., MD</creator><creator>Bullinga, John R., MD</creator><creator>Kronzon, Itzhak, MD</creator><creator>Chinitz, Larry A., MD</creator><creator>Reynolds, Harmony R., MD</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080301</creationdate><title>The Effect of Transvenous Pacemaker and Implantable Cardioverter Defibrillator Lead Placement on Tricuspid Valve Function: An Observational Study</title><author>Kim, Juyong B., MD, MPH ; Spevack, Daniel M., MD ; Tunick, Paul A., MD ; Bullinga, John R., MD ; Kronzon, Itzhak, MD ; Chinitz, Larry A., MD ; Reynolds, Harmony R., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-ec34e1f0bc2f0185c1d7457e398223bec9a62a7d334d3aab9a305c674ddd36753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>Cardiovascular</topic><topic>Defibrillators, Implantable - statistics & numerical data</topic><topic>Electrodes, Implanted - statistics & numerical data</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>New York - epidemiology</topic><topic>Pacemaker, Artificial - statistics & numerical data</topic><topic>Prosthesis Implantation - methods</topic><topic>Prosthesis Implantation - statistics & numerical data</topic><topic>Risk Assessment - methods</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><topic>Tricuspid Valve Insufficiency - diagnostic imaging</topic><topic>Tricuspid Valve Insufficiency - epidemiology</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Juyong B., MD, MPH</creatorcontrib><creatorcontrib>Spevack, Daniel M., MD</creatorcontrib><creatorcontrib>Tunick, Paul A., MD</creatorcontrib><creatorcontrib>Bullinga, John R., MD</creatorcontrib><creatorcontrib>Kronzon, Itzhak, MD</creatorcontrib><creatorcontrib>Chinitz, Larry A., MD</creatorcontrib><creatorcontrib>Reynolds, Harmony R., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Society of Echocardiography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Juyong B., MD, MPH</au><au>Spevack, Daniel M., MD</au><au>Tunick, Paul A., MD</au><au>Bullinga, John R., MD</au><au>Kronzon, Itzhak, MD</au><au>Chinitz, Larry A., MD</au><au>Reynolds, Harmony R., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effect of Transvenous Pacemaker and Implantable Cardioverter Defibrillator Lead Placement on Tricuspid Valve Function: An Observational Study</atitle><jtitle>Journal of the American Society of Echocardiography</jtitle><addtitle>J Am Soc Echocardiogr</addtitle><date>2008-03-01</date><risdate>2008</risdate><volume>21</volume><issue>3</issue><spage>284</spage><epage>287</epage><pages>284-287</pages><issn>0894-7317</issn><eissn>1097-6795</eissn><abstract>This study assessed the effect of transtricuspid placement of permanent pacemaker (PPM) and implantable cardioverter defibrillator (ICD) leads on tricuspid regurgitation (TR) in 248 patients with echocardiograms before and after placement. Some 21.2% of patients with baseline mild TR or less developed abnormal TR (3.4% mild-moderate, 12.8% moderate, 1.1% moderate-severe, 3.9% severe) after implant. TR worsened by 1 grade or more after implant in 24.2% (20.7% of PPMs vs. 32.4% of ICDs; P < .05). TR worsening was more common with ICDs than PPMs in patients with baseline mild TR or less. After lead implantation, abnormal TR developed in 21.2% and severe TR developed in 3.9% of patients with initially normal TR. TR worsened by at least 1 grade in 24.2%. Patients with ICDs had a higher rate of TR worsening compared with patients with PPMs (32.4% vs. 20.1%; P < .05).</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>17604958</pmid><doi>10.1016/j.echo.2007.05.022</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0894-7317 |
| ispartof | Journal of the American Society of Echocardiography, 2008-03, Vol.21 (3), p.284-287 |
| issn | 0894-7317 1097-6795 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70354631 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Aged Cardiovascular Defibrillators, Implantable - statistics & numerical data Electrodes, Implanted - statistics & numerical data Female Humans Incidence Male New York - epidemiology Pacemaker, Artificial - statistics & numerical data Prosthesis Implantation - methods Prosthesis Implantation - statistics & numerical data Risk Assessment - methods Risk Factors Treatment Outcome Tricuspid Valve Insufficiency - diagnostic imaging Tricuspid Valve Insufficiency - epidemiology Ultrasonography |
| title | The Effect of Transvenous Pacemaker and Implantable Cardioverter Defibrillator Lead Placement on Tricuspid Valve Function: An Observational Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A02%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effect%20of%20Transvenous%20Pacemaker%20and%20Implantable%20Cardioverter%20Defibrillator%20Lead%20Placement%20on%20Tricuspid%20Valve%20Function:%20An%20Observational%20Study&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Echocardiography&rft.au=Kim,%20Juyong%20B.,%20MD,%20MPH&rft.date=2008-03-01&rft.volume=21&rft.issue=3&rft.spage=284&rft.epage=287&rft.pages=284-287&rft.issn=0894-7317&rft.eissn=1097-6795&rft_id=info:doi/10.1016/j.echo.2007.05.022&rft_dat=%3Cproquest_cross%3E70354631%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70354631&rft_id=info:pmid/17604958&rft_els_id=1_s2_0_S0894731707003999&rfr_iscdi=true |